Live
FierceBiotechLauxera Capital Partners raises a hefty €520M for health, medtech companiesFierceBiotechHerantis taps Indivi for digital biomarker tech in Parkinson’s disease trialEndpoints NewsNourish raises $100M for virtual nutrition careBioWorldAppointments and advancements for May 19, 2026BioWorldFinancings for May 19, 2026BioWorldIn the clinic for May 19, 2026BioWorldOther news to note for May 19, 2026BioWorldRegulatory actions for May 19, 2026Endpoints NewsRelay's PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study10x Genomics NewsUnderstanding plate, droplet and microwell approaches in single-cell RNA sequencing - News-MedicalLonza NewsGlobal Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG - Yahoo Finance SingaporeFierceBiotechRelay ‘full steam ahead’ on PI3K inhibitor fueled by first phase 2 data in blood vessel disorder
Body unavailable. Use the original source.